Private company

Talkspace, Inc.

Talkspace, Inc. is an American health services company, incorporated in Delaware.1 It is headquartered in New York, New York.1

Last updated Oct 21, 2026.

Overview

  • IndustryServices-Health Services1
  • HeadquartersNew York, New York1
  • Incorporated inDE2
  • Business address622 Third Avenue, New York, Ny 100172
  • Filer categoryAccelerated filer2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

1.4%Operating margin4
3.4%Net margin5
22.0%Revenue growth, 20254
6.7%Return on equity4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Research and development4¢$9.5M
  • Other costs92¢$211.0M
  • Income tax0¢$574.0K
  • Profit3¢$7.8M

Out of $228.9M in revenue.45

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks100¢$17.2M

Out of $8.5M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.4

Financial statements

Revenue67894$228.9M in 2025+499% since 2019
0$100.0M$200.0M$300.0M2019: $38.2M$38.2M20192020: $76.2M$76.2M2020+100%2021: $113.7M$113.7M2021+49%2022: $119.6M$119.6M2022+5%2023: $150.0M$150.0M2023+25%2024: $187.6M$187.6M2024+25%2025: $228.9M$228.9M2025+22%
Gross profit6789$85.8M in 2024+326% since 2019
0$25.0M$50.0M$75.0M$100.0M2019: $20.1M$20.1M20192020: $49.8M$49.8M2020+148%2021: $66.8M$66.8M2021+34%2022: $60.3M$60.3M2022−10%2023: $74.4M$74.4M2023+23%2024: $85.8M$85.8M2024+15%
Operating income67894$3.2M in 2025
-$100.0M-$75.0M-$50.0M-$25.0M0$25.0M2019: -$29.4M-$29.4M20192020: -$22.0M-$22.0M2020−25%2021: -$93.9M-$93.9M2021+327%2022: -$83.2M-$83.2M2022−11%2023: -$23.2M-$23.2M2023−72%2024: -$4.5M-$4.5M2024−81%2025: $3.2M$3.2M2025
Net income675$7.8M in 2025
-$100.0M-$75.0M-$50.0M-$25.0M0$25.0M2019: -$29.1M-$29.1M20192020: -$22.4M-$22.4M2020−23%2021: -$62.7M-$62.7M2021+180%2022: -$79.7M-$79.7M2022+27%2023: -$19.2M-$19.2M2023−76%2024: $1.1M$1.1M20242025: $7.8M$7.8M2025+579%
Fiscal year2019202020212022202320242025
Revenue$38.2M6$76.2M7$113.7M8$119.6M9$150.0M4$187.6M4$228.9M4
Cost of revenue$18.0M6$26.4M7$46.9M8$59.2M9$75.7M9$101.8M9
Gross profit$20.1M6$49.8M7$66.8M8$60.3M9$74.4M9$85.8M9
Research and development$12.0M6$9.6M7$15.9M8$21.7M9$17.1M4$10.3M4$9.5M4
Operating expenses$160.7M8$143.5M9$173.3M4$192.1M4$225.7M4
Operating income-$29.4M6-$22.0M7-$93.9M8-$83.2M9-$23.2M4-$4.5M4$3.2M4
Income before tax-$62.7M8-$79.4M9-$19.0M4$1.2M4$8.4M4
Income tax$8.0K6$24.0K7$47.0K8$254.0K9$218.0K4$94.0K4$574.0K4
Net income-$29.1M6-$22.4M7-$62.7M5-$79.7M5-$19.2M5$1.1M5$7.8M5
Earnings per share-$1.677-$0.728-$0.519-$0.124$0.014$0.054
Earnings per share (diluted)-$1.677-$0.728-$0.519-$0.124$0.014$0.044
Shares (weighted, basic)86.8M shares8156.9M shares9165.0M shares4168.9M shares4167.1M shares4
Shares (weighted, diluted)86.8M shares8156.9M shares9165.0M shares4176.5M shares4173.6M shares4

Compare Talkspace, Inc. with another company

Corporate structure

Talkspace, Inc. sits at the top of its group. 4 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Talkspace, Inc.

  • Talkspace, Inc. New York, New York
    • Groop Internet Platform Israel LTD Subsidiary · Israel
    • Sentia AI LLC Subsidiary · Delaware, United States
    • Teenspace LLC Subsidiary · Delaware, United States

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Talkspace, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$18.9M4 Dec 31, 2025$7.4M4 Dec 31, 2024+155.9%
Accumulated depreciation$3.1M4 Dec 31, 2025$1.1M4 Dec 31, 2024+175.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$37.4M4 Dec 31, 2025$76.7M4 Dec 31, 2024−51.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$3.3M4 Dec 31, 2025$04 Dec 31, 2024
Accumulated amortization-$2.4M4 Dec 31, 2025-$1.9M4 Dec 31, 2024−31.0%
Finite-lived intangibles, net$3.9M4 Dec 31, 2025$1.3M4 Dec 31, 2024+188.7%

Properties, in its own words

Our headquarters, located in midtown Manhattan, NYC, is available to NYC-area employees who typically work a hybrid schedule. As of December 31, 2025, the majority of our employees are working remotely.

We have limited operations outside the United States. We have one foreign subsidiary located in Israel which leases its operating facilities under a month-to-month operating lease agreement.

The rest of Item 2

We do not view any of our leased facilities as material to our business.

Item 2 of the 10-K filed Mar 13, 2026.12

Leadership

Who has led Talkspace, Inc., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (22)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Groop Internet Platform Israel LTD Israel3
  • Sentia AI LLC Delaware3
  • Talkspace LLC Delaware3
  • Teenspace LLC Delaware3

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • Hudson Executive Investment Corp.Feb 21, 2020 to Jun 17, 20212

Timeline

  1. Aug 17, 20268-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights36
  2. Aug 12, 20268-K Other events37
  3. May 29, 20268-K Shareholder vote; Other events38
  4. Mar 9, 20268-K Other events39
  5. Mar 9, 20268-K Entered a material agreement40
  6. Feb 19, 20268-K Results of operations; Regulation FD disclosure41
  7. Jan 15, 20268-K Regulation FD disclosure42
  8. Oct 30, 20258-K Results of operations; Regulation FD disclosure43
  9. Oct 6, 20258-K Regulation FD disclosure44
  10. Aug 5, 20258-K Results of operations; Regulation FD disclosure45
  11. Jun 23, 20258-K Shareholder vote46
  12. May 6, 20258-K Results of operations; Regulation FD disclosure47
  13. Jun 24, 2021New chief executive Oren Frank becomes CEO13

Calendar

When it reported results

  1. Feb 19, 2026Reported quarterly or annual results41
  2. Oct 30, 2025Reported quarterly or annual results43
  3. Aug 5, 2025Reported quarterly or annual results45
  4. May 6, 2025Reported quarterly or annual results47
  5. Feb 20, 2025Reported quarterly or annual results48
  6. Oct 29, 2024Reported quarterly or annual results49
  7. Aug 6, 2024Reported quarterly or annual results50
  8. May 7, 2024Reported quarterly or annual results51

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

347 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 49 major events, 190 insider forms, 30 large holders, 56 other. The latest 20:

  1. Aug 27, 202615-12G EDGAR
  2. Aug 17, 20264 EDGAR
  3. Aug 17, 20264 EDGAR
  4. Aug 17, 20264 EDGAR
  5. Aug 17, 20264 EDGAR
  6. Aug 17, 20264 EDGAR
  7. Aug 17, 20264 EDGAR
  8. Aug 17, 20264 EDGAR
  9. Aug 17, 20264 EDGAR
  10. Aug 17, 20264 EDGAR
  11. Aug 17, 20264 EDGAR
  12. Aug 17, 20264 EDGAR
  13. Aug 17, 20264 EDGAR
  14. Aug 17, 20264 EDGAR
  15. Aug 17, 2026SCHEDULE 13D/A EDGAR
  16. Aug 17, 2026SCHEDULE 13D/A EDGAR
  17. Aug 17, 2026S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 EDGAR
  18. Aug 17, 2026S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 EDGAR
  19. Aug 17, 2026S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 EDGAR
  20. Aug 17, 2026S-8 POS POST-EFFECTIVE AMENDMENT NO. 1 EDGAR

The 347 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

29 open-market trades by officers, directors and large owners since October 2021: 13 buys and 16 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 18, 2026Reilly John CharlesChief Legal Officer, SecretarySale40,289$5.20$209.5KForm 4
Jun 12, 2026Reilly John CharlesChief Legal Officer, SecretarySale55,144$5.21$287.3KForm 4
Dec 11, 2025Margolin GilChief Technology OfficerSale14,542$3.26$47.4KForm 4
Dec 2, 2025Margolin GilChief Technology OfficerSale3,516$3.15$11.1KForm 4
Sep 12, 2025Margolin GilChief Technology OfficerSale19,563$2.58$50.5KForm 4
Sep 2, 2025Margolin GilChief Technology OfficerSale3,516$2.63$9.2KForm 4
Jun 16, 2025Margolin GilChief Technology OfficerSale19,302$2.91$56.2KForm 4
Jun 6, 2025Watson KatelynChief Marketing OfficerSale39,000$3.30$128.7KForm 4
Jun 2, 2025Margolin GilChief Technology OfficerSale3,516$3.24$11.4KForm 4
Mar 10, 2025Margolin GilChief Technology OfficerSale19,373$2.77$53.7KForm 4
Mar 5, 2025Harris Ian JiroChief Financial OfficerBuy5,934$2.80$16.6KForm 4
Mar 4, 2025Harris Ian JiroChief Financial OfficerBuy13,797$2.72$37.5KForm 4
Mar 3, 2025Harris Ian JiroChief Financial OfficerBuy11,113$2.87$31.9KForm 4
Mar 3, 2025Margolin GilChief Technology OfficerSale3,517$2.89$10.2KForm 4
Feb 28, 2025Cohen Jon RChief Executive OfficerBuy75,000$2.86$214.5KForm 4
Feb 27, 2025Reilly John CharlesChief Legal Officer, SecretaryBuy1,800$2.81$5.1KForm 4
Feb 26, 2025Reilly John CharlesChief Legal Officer, SecretaryBuy1,800$2.88$5.2KForm 4
Feb 25, 2025Reilly John CharlesChief Legal Officer, SecretaryBuy5,470$2.88$15.8KForm 4
Feb 25, 2025Reilly John CharlesChief Legal Officer, SecretaryBuy5,470$2.88$15.8KForm 4
Nov 20, 2024Margolin GilChief Technology OfficerSale134,654$3.10$417.4KForm 4

All 29 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2024Jon CohenChief Executive Officer71$600.0K$1.9M67
2024Jennifer FulkFormer Chief Financial Officer$153.0K$1.8M67
2024Ian HarrisChief Financial Officer36$233.0K$1.3M67
2024Gil MargolinChief Technology Officer48$400.0K$1.0M67
2023Jennifer FulkFormer Chief Financial Officer$400.0K$1.4M67
2023Jon CohenChief Executive Officer71$600.0K$1.3M67
2023Gil MargolinChief Technology Officer48$400.0K$1.1M67

SEC filer profile

How Talkspace, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARTalkspace, Inc.1
  • CIK0001803901
  • Employer ID (EIN)84-463660412
  • Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company12
  • Incorporated inDelaware12
  • Fiscal year endsDecember 311
  • Industry code (SIC)8000 Services-Health Services1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address622 Third Avenue, New York, NY 100171
  • Mailing address2578 Broadway #607, New York, NY 100251
  • Phone(212) 284-72061
  • Shares outstanding165,823,816 as of Aug 5, 202611
  • Public float$393.2M as of Jun 30, 202512
  • AuditorKost Forer Gabbay & Kasierer, a member of EY Global, Tel-Aviv, Israel PCAOB ID 1281; it also attests to the company’s internal control over financial reporting12
  • On EDGAR sinceFeb 21, 20201
  • Filings471 in all: 4 (197), 8-K (59), 3 (27), 10-Q (19), 424B3 (17), 425 (17), SC 13G/A (11), SC 13G (10)1
    All 44 form types

    UPLOAD (10), CORRESP (9), 144 (8), DEFA14A (7), 10-K (6), SCHEDULE 13G/A (6), EFFECT (5), S-4/A (5), S-8 (5), S-8 POS (5), SCHEDULE 13G (5), DEF 14A (4), SC 13D (4), SCHEDULE 13D/A (4), 10-K/A (3), 25-NSE (3), SC 13D/A (3), DEFM14A (2), POS AM (2), S-1 (2), 10-Q/A (1), 144/A (1), 15-12G (1), 4/A (1), 424B4 (1), 8-A12B (1), 8-K/A (1), CERT (1), DRS (1), DRS/A (1), NT 10-Q (1), PRE 14A (1), PREM14A (1), S-1/A (1), S-1MEF (1), S-4 (1)

  • Latest filingsAnnual report (10-K) Mar 13, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Proxy statement (DEF 14A) Apr 30, 2025
    Latest 8-K (8-K) Aug 17, 2026

Securities registered for trading

ClassSymbolExchange
Common stock, par value $0.0001 per shareTALKThe NASDAQ Stock Market LLC
Warrants to purchase common stockTALKWThe NASDAQ Stock Market LLC

From the cover page of the 10-K filed Mar 13, 2026 (Section 12(b) of the Exchange Act).12

Risk factors and legal proceedings

The risks Talkspace, Inc. names in Item 1A of its 10-K filed Mar 13, 2026: 63 risks under these headings, as written.12

  • In the course of conducting our business operations, we are exposed to a variety of risks. Any of the risk factors we describe below have affected or could materially adversely affect our business, financial condition and results of operations. Certain statements in “Risk Factors” are forward-looking statements, see “Forward-Looking Statements” in Part II Item 7.
  • Unless the context otherwise requires, all references in this subsection as to “Talkspace,” the “Company,” “we,” “us” or “our” refer to the business of Talkspace, Inc. and its consolidated subsidiaries.
  • Risks Related to the Pending Merger with Universal Health Services, Inc.
  • Risks Related to our Operating Results
  • Risks Related to our Business and Industry
  • Risks Related to our Legal and Regulatory Environment
  • Risks Related to our Intellectual Property
  • Risks Related to Ownership of our Common Stock, our Warrants and Operating as a Public Company
  • RISKS RELATED TO THE PENDING MERGER WITH UNIVERSAL HEALTH SERVICES, INC.
  • The announcement and pendency of the Merger may result in disruptions to our business, divert management's attention, disrupt our relationships with third parties and employees any of which could negatively impact our operating results and ongoing business.
  • Failure to complete the Merger could negatively impact our stock price and future business. The Merger is subject to several closing conditions, including the approval by our stockholders, regulatory clearances, and other customary closing conditions, which may not be satisfied at all or in the anticipated timeframe.
  • The Merger Agreement contains provisions that limit our ability to pursue alternative transactions and may require us to pay a substantial termination fee.
The other 55 risks
  • We may be targets of securities class action and derivative lawsuits, which could result in substantial costs and may prevent or delay consummation of the Merger, divert management’s attention, and otherwise materially harm our business.
  • We have incurred, and will continue to incur, significant direct and indirect costs as a result of the Merger.
  • If the Merger is not consummated, our stock price may decline, and we will have incurred substantial costs.
  • RISKS RELATED TO OUR OPERATING RESULTS
  • We may not grow at the rates we historically have achieved or at all, even if our key metrics may indicate growth, and we may experience difficulties in managing our growth and expanding our operations, which could have a material adverse effect on the market price of our common stock.
  • RISKS RELATED TO OUR BUSINESS AND INDUSTRY
  • Rapid technological change in our industry presents us with significant risks and challenges.
  • We operate in a competitive industry, and if we are not able to compete effectively, our business, financial condition and results of operations will be harmed.
  • We derive a material portion of our revenue from our largest customers. The loss, termination, or renegotiation of any contract with such customers could negatively impact our results.
  • If we are unable to secure customers' contract renewals, our business, financial condition and results of operations will be harmed.
  • The future growth and profitability of our business will depend in large part upon the effectiveness and efficiency of our marketing efforts, and our ability to develop brand awareness cost-effectively.
  • We may be unsuccessful in achieving broad market education and changing consumer purchasing habits.
  • Our growth depends in part on the success of our strategic relationships with third parties that we provide services to.
  • Our virtual behavioral healthcare strategies depend on our ability to maintain and expand our network of therapists, psychiatrists and other providers. If we are unable to do so, our future growth would be limited and our business, financial condition and results of operations would be harmed.
  • Developments affecting spending by the healthcare industry could adversely affect our business.
  • Negative media coverage and social media engagement could adversely affect our business.
  • We may become subject to medical liability claims, which could cause us to incur significant expenses and may require us to pay significant damages if not covered by insurance.
  • A decline in the prevalence of enterprise-sponsored healthcare or the emergence of new technologies may adversely impact our DTE business or require us to expend significant resources in order to remain competitive.
  • We rely on third-party platforms such as the Apple App Store and Google Play App Store, to distribute our platform and offerings.
  • We rely on data center providers, Internet infrastructure, bandwidth providers, third-party computer hardware and software, other third parties and our own systems for providing services to our customers and members, and any failure or interruption in the services provided by these third parties or our own systems could expose us to litigation and negatively impact our relationships with customers and members, adversely affecting our brand and our business.
  • We and our third-party vendors have experienced cybersecurity incidents from time to time. If our or our vendors’ security measures fail or are breached in the future and unauthorized access to a customer’s data or information systems is obtained, our services may be perceived as insecure, we may incur significant liabilities, our reputation may be harmed, and we could lose sales, customers and members.
  • There may be adverse tax, legal and other consequences if the employment status of providers on our platform is challenged.
  • Changes in consumer sentiment or laws, rules or regulations regarding the use of cookies, and other tracking technologies and other privacy matters could have a material adverse effect on our ability to generate net revenues and could adversely affect our ability to collect proprietary data on consumer behavior.
  • Certain U.S. state and local tax authorities may assert that we have a nexus with such states or localities and may seek to impose state and local income taxes on our income allocated to such state and localities and assert we are required to collect sales and use taxes.
  • Our ability to use our net operating losses and certain other attributes may be subject to certain limitations.
  • We depend on our senior management team, and the loss of one or more of our executive officers or key employees or an inability to attract and retain highly skilled employees could adversely affect our business.
  • We may acquire other companies or technologies, which could divert our management’s attention, result in dilution to our stockholders and otherwise disrupt our operations and we may have difficulty integrating any such acquisitions successfully or realizing the anticipated benefits therefrom, any of which could have a material adverse effect on our business, financial condition and results of operations.
  • RISKS RELATED TO OUR LEGAL AND REGULATORY ENVIRONMENT
  • Our business could be adversely affected by legal challenges to our business model or by actions restricting our ability to provide the full range of our services in certain jurisdictions.
  • Evolving government regulations may result in increased costs or adversely affect our results of operations.
  • We are dependent on our relationships with affiliated professional entities, which we do not own, to provide physician and other professional services, and our business, financial condition and our ability to operate in certain jurisdictions would be adversely affected if those relationships were disrupted or if our arrangements with our providers or customers are found to violate state laws prohibiting the corporate practice of medicine or fee splitting.
  • The impact on us of ongoing healthcare legislation and other changes in the healthcare industry and in healthcare spending is currently unknown, but may adversely affect our business, financial condition and results of operations.
  • We conduct business in a heavily regulated industry and if we fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes to our operations or experience adverse publicity, which could have a material adverse effect on our business, financial condition, and results of operations.
  • Our use and disclosure of personal information, including PHI, personal data, and other health information, is subject to state, federal or other privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm and, in turn, a material adverse effect on our customer base and member bases and revenue.
  • We may be exposed to compliance obligations and risks under anti-corruption, export controls and economic sanctions laws and regulations of the United States and applicable non-U.S. jurisdictions, and any instances of noncompliance could have a material adverse effect on our reputation and the results of our operations.
  • RISKS RELATED TO OUR INTELLECTUAL PROPERTY
  • Any failure to protect, enforce or defend our intellectual property rights could impair our ability to protect our technology and our brand.
  • Third parties may challenge the validity of our trademarks and patents or oppose trademark and patent applications. Companies with other patents could require us to stop using or pay to use required technology.
  • We could incur substantial costs as a result of any claim of infringement of another party’s intellectual property rights.
  • Our proprietary software may not operate properly, which could damage our reputation, give rise to claims against us or divert application of our resources from other purposes, any of which could harm our business, financial condition and results of operations.
  • We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances or partnerships with third-parties that may not result in the development of commercially viable solutions or the generation of significant future revenues.
  • RISKS RELATED TO OWNERSHIP OF OUR COMMON STOCK, OUR WARRANTS AND OPERATING AS A PUBLIC COMPANY
  • If we fail to maintain effective internal control over financial reporting in the future, our ability to produce accurate and timely financial statements could be impaired, which may adversely affect investor confidence in us and, as a result, the value of our common stock.
  • Delaware law and our organizational documents contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
  • The provision of our Certificate of Incorporation requiring exclusive forum in certain courts in the State of Delaware or the federal district courts of the United States for certain types of lawsuits may have the effect of discouraging lawsuits against our directors and officers.
  • Future sales and resales of our common stock may cause the market price of our securities to drop significantly, even if our business is doing well.
  • An investor's percentage of ownership in the Company may be diluted in the future.
  • We do not intend to pay cash dividends for the foreseeable future.
  • You may only be able to exercise your public warrants on a “cashless basis” under certain circumstances, and if you do so, you will receive fewer shares of common stock from such exercise than if you were to exercise such warrants for cash.
  • We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be shortened and the number of common stock purchasable upon exercise of a warrant could be decreased, all without your approval.
  • The Warrant Agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with us.
  • We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
  • GENERAL RISK FACTORS
  • The price of our securities may be volatile.
  • Economic uncertainties or downturns in the general economy or the industries in which our customers operate could disproportionately affect the demand for our solution and negatively impact our results of operations.
  • We may need to raise additional capital in the future in order to execute our business plans, which may not be available on terms acceptable to us, or at all.
  • Changes in tax laws could adversely affect our operating results and financial condition.
  • We may be subject to litigation, which is expensive, time-consuming and could divert management attention.
  • Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common stock.
  • We could experience losses or liability not covered by insurance.

Legal proceedings

We have no material pending legal proceedings as of December 31, 2025, however we may in the future be involved in various legal proceedings, claims and litigation that arise in the normal course of business. We accrue for estimated loss contingencies related to legal matters when available information indicates that it is probable a liability has been incurred and we can reasonably estimate the amount of that loss. In many proceedings, however, it is inherently difficult to determine whether any loss is probable or even possible or to estimate the amount of any loss. In addition, even where a loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is often not possible to reasonably estimate the size of the possible loss or range of loss or possible additional losses.

For additional information, see Note 8, “Commitments and Contingent Liabilities,” in the notes to the consolidated financial statements included in Part II, Item 8 of this Form 10-K.

The opening of Item 3, Legal Proceedings.12

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
    SEC EDGAROther events
  38. 38
  39. 39
    SEC EDGAROther events
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67